返回
Swedish Orphan Biovitrum AB (publ)（BIOVF）价格
BIOVF 股价走势图
BIOVF 收益
Swedish Orphan Biovitrum AB (publ)
$37
0%
$0
收盘价：Jan 16, 16:00:00 GMT-5
$37
0%
$0
盘后：Jan 16, 20:00:00 GMT-5
最新收益结果： Q3 '25
报告： 2025-10-20
历史收益
季度性
年度
EPS
收入
Earnings FAQ
BIOVF 最近的每股收益与预期相比如何？
Swedish Orphan Biovitrum AB (publ) BIOVF 上一季度的收入表现如何？
Swedish Orphan Biovitrum AB (publ) 的收入预期是多少？
Swedish Orphan Biovitrum AB (publ) 的盈利质量评分是多少？
Swedish Orphan Biovitrum AB (publ) 何时发布财报？
Swedish Orphan Biovitrum AB (publ) 的预期收益是多少？
Swedish Orphan Biovitrum AB (publ) 是否超出收益预期？
关键数据
前收盘价
$37
开盘价
$32.06
当日区间
$32.06 - $37
52周范围
$25.79 - $37
交易量
1
平均成交量
26
每股收益（TTM）
0.00
股息收益率
--
市值
$12.7B
什么是 BIOVF？
Swedish Orphan Biovitrum AB engages in the research, development, manufacture, and sale of pharmaceuticals. The company is headquartered in Stockholm, Stockholm and currently employs 1,890 full-time employees. The company went IPO on 2006-09-15. The firm develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care. The Company’s product portfolio is divided into three business segments: the Core Products segment offers pharmaceuticals within Inflammation area, and Genetics and metabolic therapeutic area; the Partner Products segment offers about 40 pharmaceuticals within hematology, oncology and emergency medicines, and the ReFacto Manufacturing segment. The firm has subsidiaries in Sweden, Denmark, Finland, Norway, United Kingdom and France, among others.